Zhejiang Chengyi Pharmaceutical Co. Ltd. Class ASSE: 603811

Announcement on Remunerations for Directors and Senior Management Members in 2025 and 2026 Remuneration Plan

· Issued by Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Remunerations for Directors and Senior Management Members in 2025 and 2026 Remuneration Plan

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis